Civic Intelligence

The Side-Out Foundation

990 • Fiscal year 2022 • EIN 20-2510044

Apr 01, 2021 to Mar 31, 2022 • Filed on Oct 19, 2022

Organization Profilewww.side-out.org
11208 Waples Mill Road 103Fairfax, VA 22030

(877) 344-7465

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

53rd percentile

0.08x

Higher debt load relative to assets than 53% of similar nonprofits.

2022 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2022

Liabilities / Revenue

59th percentile

0.13x

Higher debt load relative to revenue than 59% of similar nonprofits.

2022 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2022

Net Margin

20th percentile

-11%

Higher net margin than 20% of similar nonprofits.

2022 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2022

Top Officer Pay

59th percentile

$79,016

Higher top officer pay than 59% of similar nonprofits.

Top officer pay equals 6.9% of source-year revenue.

2022 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2022

Asset Growth

36th percentile

-3.0%

Faster asset growth than 36% of similar nonprofits.

2022 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2021 to 2022

Revenue Growth

95th percentile

186%

Faster revenue growth than 95% of similar nonprofits.

2022 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2021 to 2022

Balance Sheet
Liabilities / Assets53rd percentile

Assets

Down

$1,966,126

Down $60,065 (-3.0%) from 2021

Net Assets

Down

$1,813,637

Down $128,870 (-6.6%) from 2021

Liabilities

Up

$152,489

Up $68,805 (+82%) from 2021

Revenue And Expenses
Liabilities / Revenue59th percentileNet Margin20th percentile

Revenue

Up

$1,141,094

Up $742,675 (+186%) from 2021

Expenses

Up

$1,269,964

Up $123,873 (+11%) from 2021

Net Income

Up

-$128,870

Up $618,802 (+83%) from 2021

Historical Trend

Balance Sheet Trend

Asset Growth36th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$4.0M$3.0M$2.0M$1.0M$0Assets 2010: $1,897,648Liabilities 2010: $0Net Assets 2010: $1,897,6482010Assets 2011: $2,525,565Liabilities 2011: $301,536Net Assets 2011: $2,224,0292011Assets 2012: $2,389,071Liabilities 2012: $5,632Net Assets 2012: $2,383,4392012Assets 2013: $2,296,463Liabilities 2013: $722,122Net Assets 2013: $1,574,3412013Assets 2014: $2,928,163Liabilities 2014: $573,305Net Assets 2014: $2,354,8582014Assets 2015: $3,184,115Liabilities 2015: $479,813Net Assets 2015: $2,704,3022015Assets 2016: $3,369,536Liabilities 2016: $34,295Net Assets 2016: $3,335,2412016Assets 2017: $3,558,731Liabilities 2017: $348,277Net Assets 2017: $3,210,4542017Assets 2018: $3,162,285Liabilities 2018: $357,077Net Assets 2018: $2,805,2082018Assets 2019: $3,118,086Liabilities 2019: $317,163Net Assets 2019: $2,800,9232019Assets 2020: $2,913,522Liabilities 2020: $223,343Net Assets 2020: $2,690,1792020Assets 2021: $2,026,191Liabilities 2021: $83,684Net Assets 2021: $1,942,5072021Assets 2022: $1,966,126Liabilities 2022: $152,489Net Assets 2022: $1,813,6372022Assets 2023: $2,116,765Liabilities 2023: $420,164Net Assets 2023: $1,696,6012023Assets 2024: $2,115,644Liabilities 2024: $246,571Net Assets 2024: $1,869,0732024Assets 2025: $2,106,993Liabilities 2025: $401,907Net Assets 2025: $1,705,0862025

Highlighted filing

2022

Assets$1,966,126
Liabilities$152,489
Net Assets$1,813,637
Open 2022 Filing

Operations Trend

Revenue Growth95th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$3.0M$2.0M$1.0M$0-$1.0MExpenses 2010: $1,135,8192010Expenses 2011: $749,7092011Expenses 2012: $1,163,5732012Revenue 2013: $1,520,932Expenses 2013: $2,330,030Net Income 2013: -$809,0982013Revenue 2014: $1,590,910Expenses 2014: $810,392Net Income 2014: $780,5182014Revenue 2015: $1,395,606Expenses 2015: $1,046,162Net Income 2015: $349,4442015Revenue 2016: $1,527,744Expenses 2016: $896,805Net Income 2016: $630,9392016Revenue 2017: $1,320,763Expenses 2017: $1,445,550Net Income 2017: -$124,7872017Revenue 2018: $30,780Expenses 2018: $436,026Net Income 2018: -$405,2462018Revenue 2019: $1,344,877Expenses 2019: $1,349,162Net Income 2019: -$4,2852019Revenue 2020: $1,396,295Expenses 2020: $1,507,039Net Income 2020: -$110,7442020Revenue 2021: $398,419Expenses 2021: $1,146,091Net Income 2021: -$747,6722021Revenue 2022: $1,141,094Expenses 2022: $1,269,964Net Income 2022: -$128,8702022Revenue 2023: $1,232,509Expenses 2023: $1,349,545Net Income 2023: -$117,0362023Revenue 2024: $1,361,469Expenses 2024: $1,188,997Net Income 2024: $172,4722024Revenue 2025: $1,478,970Expenses 2025: $1,642,957Net Income 2025: -$163,9872025

Highlighted filing

2022

Revenue$1,141,094
Expenses$1,269,964
Net Income-$128,870
Open 2022 Filing
Jump To
Filing Snapshot
Filing Period
Apr 1, 2021 to Mar 31, 2022
Signed
Oct 19, 2022
Return Version
2021v4.2
Gross Receipts
$1,154,847
Mission and Program Overview

Mission

Making breast cancer a manageable disease (similar to diabetes) takes an organization with extraordinary vision & cutting-edge tactics. The Side-Out Foundation is a 501(c)(3) non-profit organization, founded in 2004 by Richard and Bryant Dunetz, to empower a new generation of advocates, make significant and identifiable impact on the way breast cancer is treated, and give those living with metastatic breast cancer (MBC) more tomorrows.Since its inception, the foundation has (I) built educational and community-driven programs focused on teaching advocacy to the next generation of changemakers, equipping them with skills and tools to support Side-Out's mission, as well as any cause they wish to connect to in their future; (II) forged groundbreaking collaborations with prestigious research teams, hospitals, and research centers nationwide and; (III) leveraged new technologies to improve, alter cancer trajectories, and constantly challenge the foundation of cancer care.

Balance Sheet Detail
LineBeginningEndChange
Assets
Cash and Non-Interest-Bearing Accounts$1,921,427$1,911,614▼ $9,813
Land, Buildings, and Equipment, Net$70,305$31,119▼ $39,186
Pledges and Grants Receivable$24,388$13,322▼ $11,066
Inventories for Sale or Use$3,795$3,795→ $0
Prepaid Expenses and Deferred Charges$348$348→ $0
Total Assets$2,026,191$1,966,126▼ $60,065
Other Assets Total$5,928$5,928→ $0
Liabilities
Other Liabilities$67,628$129,501▲ $61,873
Accounts Payable and Accrued Expenses$16,056$22,988▲ $6,932
Total Liabilities$83,684$152,489▲ $68,805
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$1,942,507$1,813,637▼ $128,870
Total Net Assets Fund Balance$1,942,507$1,813,637▼ $128,870
Total Liabilities and Net Assets / Fund Balance$2,026,191$1,966,126▼ $60,065

Asset Categories

AssetBook ValueDepreciationBasis
Other Land Buildings$22,756$492,094$514,850
Equipment$6,790$20,139$26,929
Leasehold Improvements$1,573$302$1,875
Compensation and Service Providers
Top Officer Pay59th percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
Rick DunetzExecutive DirectorFT$76,983$2,033$79,016

Board Members and Trustees

NameTitle
Gary ThompsonBoard chair
Stephanie ReffeyDirector
Revenue and Support

Revenue Composition

Contributions and Grants
$1,127,967
Program Service Revenue
$0
Investment Income
$102
Other Revenue
$13,025
All Other Contributions
$1,127,967
Change in Net Assets
$-128,870

Audited Revenue Reconciliation

Revenue per Audited Statements
$1,141,094
Revenue Not Reported on Financial Statements
$0
Revenue Not Reported on Form 990
$7,461
Total Revenue per Audited Statements
$1,148,555
Total Revenue per Form 990
$1,141,094
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$783,061
Salaries, Compensation, and Employee Benefits$473,516
Total Fundraising Expense$73,074
Grants and Similar Amounts Paid$13,387
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Other Salaries and Wages$254,317$66,153$10,287$330,757
Fees for Services Other$72,731$12,400$5,783$90,914
Current Officers, Directors, Trustees, and Key Employees$31,566$15,783$31,566$78,915
Occupancy$52,348$9,815$3,272$65,435
Advertising$9,733$38,933-$48,666
Fees for Services Accounting-$32,611$13,976$46,587
Depreciation Depletion$38,236$4,248-$42,484
Payroll Taxes$25,070$7,135$3,471$35,676
Other Employee Benefits$15,277$3,950$525$19,752
All Other Expenses$6,409$8,355$400$15,164
Grants to Domestic Individuals$12,000--$12,000
Insurance$11,756--$11,756
Office Expenses-$11,134-$11,134
Pension Plan Contributions$6,509$1,683$224$8,416
Other Expenses$5,413$1,015$338$6,766
Travel$4,455-$448$4,903
Information Technology$3,817$716$239$4,772
Grants to Domestic Orgs$1,387--$1,387
Fees for Services Legal$99--$99
Total Functional Expenses$976,733$220,157$73,074$1,269,964

Audited Expense Reconciliation

Line ItemAmount
Total Expenses per Audited Statements$1,277,425
Expenses per Audited Statements$1,269,964
Total Expenses per Form 990$1,269,964
Expenses Not Reported on Form 990$7,461
Expenses Not Reported on Financial Statements$0
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Clinical trial liabilities$98,269
Deferred rent$31,232
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
No
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
Yes
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section A, line 2

“Bryant Dunetz and Rick Dunetz are related.”

Form 990, Part VI, Section B, line 11B

“The Executive Director and Secretary review the return.”

Form 990, Part VI, Section B, line 12C

“Written conflict of interest policy is in place and monitored at all levels of the organization.”

Form 990, Part VI, Section B, line 15

“The Board reviews and approves compensation for all leadership positions.”

Form 990, Part VI, Section C, line 19

“No other documents are available to the public.”

Filing and Contact Details

Filer

Filer Name
The Side-Out Foundation
EIN
20-2510044
Phone
8773447465
Address
11208 Waples Mill Road 103, Fairfax, VA 22030

Signing Officer

Name
Rick Dunetz
Title
Executive Director
Phone
8773447465
Signed
2022-10-19
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Rick Dunetz
Formed
2005
Legal Domicile
Va
Voting Board Members
3
Independent Board Members
2
Employees
8
Volunteers
0

Preparer

Firm
Kositzka Wicks and Company
Address
5270 Shawnee Road Suite 250, Alexandria, VA 22312
Preparer
Jennifer S Manster CPA
Phone
7036422700
Supplemental Narrative

Additional Explanations

Form 990, Part III, Line 1 - Organization Mission

“The Side-Out Foundation was established to educate, empower, and unite the volleyball community through outreach, and drive change in the way that breast cancer is treated by owning and managing its very own game-changing stage IV breast cancer clinical trial, the Side-Out Protocol. Making breast cancer a manageable disease (similar to diabetes) takes an organization with extraordinary vision & cutting-edge tactics. The Side-Out Foundation is a 501(c)(3) non-profit organization, founded in 2004 by Richard and Bryant Dunetz, to empower a new generation of advocates, make significant and identifiable impact on the way breast cancer is treated, and give those living with metastatic breast cancer (MBC) more tomorrows. Since its inception, the foundation has (I) built educational and community-driven programs focused on teaching advocacy to the next generation of changemakers, equipping them with skills and tools to support Side-Out's mission, as well as any cause they wish to connect to in their future; (II) forged groundbreaking collaborations with prestigious research teams, hospitals, and research centers nationwide and; (III) leveraged new technologies to improve, alter cancer trajectories, and constantly challenge the foundation of cancer care so as to significantly extend the lives of those living with MBC. For 10 years the foundation's researchers studied metastatic tumor DNA and the proteins that drive them in a highly targeted research program called The Side-Out Protocol (a direct impact clinical trial managed and operated by Side-Out). This trial was the first and only of its kind to use a multi-omic (genomic, proteomic, and phosphoproteomic analysis) approach along with personalized medicine in the area of MBC research. By using this approach, The Side-Out Protocol provided patients treatment based not on their type of cancer, but on their own cancer cells' molecular architecture. The Side-Out Protocol proved that precision medicine has the ability to significantly extend the lives of those living with the most aggressive stages of breast cancer and that standard level of care as a one-size-fits-all approach is suboptimal and does not benefit every cancer patient. Moving forward, the foundation's goal is to leverage the past 10 years of its precision medicine research to provide patients and their oncologists the information they need to make an informed decision about their cancer journey and to solve some of the most challenging problems in MBC research and care. Side-Out's new metastatic breast cancer research program is available to any and all MBC patients regardless of insurance or previous care at no cost to them. This program gives patients a personalized precision medicine analysis that ranks treatment solutions and clinical trials for which they qualify. For underrepresented racial and ethnic groups, this brings them a level of care previously inaccessible to them. Further, the foundation plans to increase and diversify patient participation through a multi-faceted approach so as to reach patients directly, as well as partner with local and regional cancer centers and oncologists. The result of this will be two-fold: (I) Patients will have the opportunity to take control of their cancer journey and benefit from proven, life-extending science without the financial and emotional burden of traveling to larger cancer centers for care, and (II) These local and regional cancer centers and oncologists can provide their patients access to high-level precision medicine care, services their facilities may not currently be capable of providing due to limited resources. For every patient enrolled in our trials, Side-Out receives biomarker data that can deepen our understanding of MBC and identify evolving trends to improve outcomes. This data set is housed in Side-Out's MBC Bioinformatics Portal where oncologists, biologists, and scientists can access and use the data to further their own research. This revolutionary pro”

Financial Statement Notes

Part X, Line 2:

“On January 1, 2009, the Foundation adopted the provisions of FASB ASC Topic 740-10 Income Taxes. The implementation of FASB ASC Topic 740-10 had no impact on the Foundation's financial statements and, accordingly, no interest or penalties have been accrued. Management believes it has no material uncertain tax positions or any related penalties and interest to accrue for the year ended March 31, 2022, and accordingly, there is no liability for unrecognized benefits.”

Raw XML AppendixShowing 400 of 467 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt016056
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt022988
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0Making breast cancer a manageable disease (similar to diabetes) takes an organization with extraordinary vision & cutting-edge tactics. The Side-Out Foundation is a 501(c)(3) non-profit organization, founded in 2004 by Richard and Bryant Dunetz, to empower a new generation of advocates, make significant and identifiable impact on the way breast cancer is treated, and give those living with metastatic breast cancer (MBC) more tomorrows.Since its inception, the foundation has (I) built educational and community-driven programs focused on teaching advocacy to the next generation of changemakers, equipping them with skills and tools to support Side-Out's mission, as well as any cause they wish to connect to in their future; (II) forged groundbreaking collaborations with prestigious research teams, hospitals, and research centers nationwide and; (III) leveraged new technologies to improve, alter cancer trajectories, and constantly challenge the foundation of cancer care.
IRS990/AdvertisingGrp/ManagementAndGeneralAmt038933
IRS990/AdvertisingGrp/ProgramServicesAmt09733
IRS990/AdvertisingGrp/TotalAmt048666
IRS990/AllOtherContributionsAmt01127967
IRS990/AllOtherExpensesGrp/FundraisingAmt0400
IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt08355
IRS990/AllOtherExpensesGrp/ProgramServicesAmt06409
IRS990/AllOtherExpensesGrp/TotalAmt015164
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd00
IRS990/BackupWthldComplianceInd01
IRS990/BooksInCareOfDetail/PersonNm0Rick Dunetz
IRS990/BooksInCareOfDetail/PhoneNum07036158740
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt011208 Waple Mill Rd 103
IRS990/BooksInCareOfDetail/USAddress/CityNm0Fairfax
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0VA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd022030
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt01921427
IRS990/CashNonInterestBearingGrp/EOYAmt01911614
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd00
IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt031566
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt015783
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt031566
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt078915
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd01
IRS990/CompensationProcessOtherInd01
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/CostOfGoodsSoldAmt013753
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt01127967
IRS990/CYGrantsAndSimilarPaidAmt013387
IRS990/CYInvestmentIncomeAmt0102
IRS990/CYOtherExpensesAmt0783061
IRS990/CYOtherRevenueAmt013025
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0-128870
IRS990/CYSalariesCompEmpBnftPaidAmt0473516
IRS990/CYTotalExpensesAmt01269964
IRS990/CYTotalFundraisingExpenseAmt073074
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt01141094
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt04248
IRS990/DepreciationDepletionGrp/ProgramServicesAmt038236
IRS990/DepreciationDepletionGrp/TotalAmt042484
IRS990/Desc0Funds raised in 2021 through the Foundation's two advocacy programs Dig Pink and the Ambassador Program were used for the advancement and expansion of Side-Out's newest metastatic breast cancer (MBC) research study. Serving 50 patients in its pilot launch in fiscal year 2020, this program harnesses multi-omic advanced diagnostics to identify treatment response predictors. Such a revolutionary approach provides MBC patients and their oncologists a precise analysis, outlining treatment solutions and clinical trials that may benefit an individual patient based on their cancer's unique molecular architecture. In 2021, the Foundation served 102 patients, providing them with this comprehensive analysis to allow them to make an informed decision about their personal cancer journey. While directly helping cancer patients, this program also collected biomarker data for the diversification of Side-Out's one-of-a-kind, relational bioinformatics portal. This one-of-a-kind collection of MBC data allows science to advance and affords the opportunity to discover new targets, new treatments, and new pathways to extend the lives of those faced with this disease. The foundation's own discoveries have been presented at the San Antonio Breast Cancer Symposium in December of 2021 (the Side-Out 3 trial) and published in the journal of Molecular Oncology (the Side-Out 2 trial). Molecular Oncology is one of the most prestigious journals in the oncology category. Side-Out's work (https://pubmed.ncbi.nlm.nih.gov/34437759/) has shown that the multi-omic approach we proposed in the trial improved clinical outcomes of patients with aggressive MBC and continues to be a basis for our research moving forward.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd00
IRS990/DonorAdvisedFundInd00
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt08
IRS990/EmploymentTaxReturnsFiledInd01
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt0976733
IRS990/FamilyOrBusinessRlnInd01
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/FundraisingAmt013976
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt032611
IRS990/FeesForServicesAccountingGrp/TotalAmt046587
IRS990/FeesForServicesLegalGrp/ProgramServicesAmt099
IRS990/FeesForServicesLegalGrp/TotalAmt099
IRS990/FeesForServicesOtherGrp/FundraisingAmt05783
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt012400
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt072731
IRS990/FeesForServicesOtherGrp/TotalAmt090914
IRS990/ForeignActivitiesInd00
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt040.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt02033
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/PersonNm0Rick Dunetz
IRS990/Form990PartVIISectionAGrp/PersonNm1Gary Thompson
IRS990/Form990PartVIISectionAGrp/PersonNm2Stephanie Reffey
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt076983
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/TitleTxt0Executive Director
IRS990/Form990PartVIISectionAGrp/TitleTxt1Board chair
IRS990/Form990PartVIISectionAGrp/TitleTxt2Director
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02005
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/SeparateBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd00
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt03
IRS990/GrantAmt013387
IRS990/GrantsToDomesticIndividualsGrp/ProgramServicesAmt012000
IRS990/GrantsToDomesticIndividualsGrp/TotalAmt012000
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt01387
IRS990/GrantsToDomesticOrgsGrp/TotalAmt01387
IRS990/GrantsToIndividualsInd01
IRS990/GrantsToOrganizationsInd00
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt01154847
IRS990/GrossSalesOfInventoryAmt026778
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd01
IRS990/IndependentAuditFinclStmtInd01
IRS990/IndependentVotingMemberCnt02
IRS990/IndivRcvdGreaterThan100KCnt00
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InformationTechnologyGrp/FundraisingAmt0239
IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt0716
IRS990/InformationTechnologyGrp/ProgramServicesAmt03817
IRS990/InformationTechnologyGrp/TotalAmt04772
IRS990/InsuranceGrp/ProgramServicesAmt011756
IRS990/InsuranceGrp/TotalAmt011756
IRS990/InventoriesForSaleOrUseGrp/BOYAmt03795
IRS990/InventoriesForSaleOrUseGrp/EOYAmt03795
IRS990/InvestmentIncomeGrp/ExclusionAmt0102
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt0102
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt05
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt0512535
IRS990/LandBldgEquipBasisNetGrp/BOYAmt070305
IRS990/LandBldgEquipBasisNetGrp/EOYAmt031119
IRS990/LandBldgEquipCostOrOtherBssAmt0543654
IRS990/LegalDomicileStateCd0VA
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0See Schedule O.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd00
IRS990/NetAssetsOrFundBalancesBOYAmt01942507
IRS990/NetAssetsOrFundBalancesEOYAmt01813637
IRS990/NetIncomeOrLossGrp/ExclusionAmt013025
IRS990/NetIncomeOrLossGrp/TotalRevenueColumnAmt013025
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt01942507
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt01813637
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/FundraisingAmt03272
IRS990/OccupancyGrp/ManagementAndGeneralAmt09815
IRS990/OccupancyGrp/ProgramServicesAmt052348
IRS990/OccupancyGrp/TotalAmt065435
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt011134
IRS990/OfficeExpensesGrp/TotalAmt011134
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherAssetsTotalGrp/BOYAmt05928
IRS990/OtherAssetsTotalGrp/EOYAmt05928
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherEmployeeBenefitsGrp/FundraisingAmt0525
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt03950
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt015277
IRS990/OtherEmployeeBenefitsGrp/TotalAmt019752
IRS990/OtherExpensesGrp/Desc0Clinical trial
IRS990/OtherExpensesGrp/Desc1Subscriptions
IRS990/OtherExpensesGrp/Desc2Payroll expenses
IRS990/OtherExpensesGrp/Desc3Awards
IRS990/OtherExpensesGrp/FundraisingAmt01055
IRS990/OtherExpensesGrp/FundraisingAmt11490
IRS990/OtherExpensesGrp/FundraisingAmt2338
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt03164
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt13062
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt21015
IRS990/OtherExpensesGrp/ProgramServicesAmt0397977
IRS990/OtherExpensesGrp/ProgramServicesAmt116874
IRS990/OtherExpensesGrp/ProgramServicesAmt210759
IRS990/OtherExpensesGrp/ProgramServicesAmt35413
IRS990/OtherExpensesGrp/TotalAmt0397977
IRS990/OtherExpensesGrp/TotalAmt121093
IRS990/OtherExpensesGrp/TotalAmt215311
IRS990/OtherExpensesGrp/TotalAmt36766
IRS990/OtherLiabilitiesGrp/BOYAmt067628
IRS990/OtherLiabilitiesGrp/EOYAmt0129501
IRS990/OtherSalariesAndWagesGrp/FundraisingAmt010287
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt066153
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt0254317
IRS990/OtherSalariesAndWagesGrp/TotalAmt0330757
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PayrollTaxesGrp/FundraisingAmt03471
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt07135
IRS990/PayrollTaxesGrp/ProgramServicesAmt025070
IRS990/PayrollTaxesGrp/TotalAmt035676
IRS990/PensionPlanContributionsGrp/FundraisingAmt0224
IRS990/PensionPlanContributionsGrp/ManagementAndGeneralAmt01683
IRS990/PensionPlanContributionsGrp/ProgramServicesAmt06509
IRS990/PensionPlanContributionsGrp/TotalAmt08416
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt024388
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt013322
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt0348
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt0348
IRS990/PrincipalOfficerNm0Rick Dunetz
IRS990/ProfessionalFundraisingInd00
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt0400020
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt057395
IRS990/PYInvestmentIncomeAmt0197
IRS990/PYOtherExpensesAmt0454573
IRS990/PYOtherRevenueAmt0-1798
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt0-747672
IRS990/PYSalariesCompEmpBnftPaidAmt0634123
IRS990/PYTotalExpensesAmt01146091
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt0398419
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt0-128870
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd00
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd01
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd01
IRS990/ReportProgramRelatedInvstInd00
IRS990ScheduleA/AmountsRcvdDsqlfyPersonGrp/TotalAmt00
IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt0Cashback rebates - 2018 Amount: $ 2,325. 2020 Amount: $ 1,200.
IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc0Schedule A, Part III, Line 12, Explanation of Other Income:
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt01127967
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt0400020
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt01359341
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt01320909
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus4YearsAmt01319661
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt05527898
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearAmt0102
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus1YearAmt0197
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus2YearsAmt01138
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus3YearsAmt01357
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus4YearsAmt01102
IRS990ScheduleA/GrossInvestmentIncome509Grp/TotalAmt03896
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt026778
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus1YearAmt07460
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus2YearsAmt044471
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus3YearsAmt051066
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt0129775
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearAmt0102
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus1YearAmt0197
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus2YearsAmt01138
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus3YearsAmt01357
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus4YearsAmt01102
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/TotalAmt03896
IRS990ScheduleA/InvestmentIncomeCYPct00.00070
IRS990ScheduleA/InvestmentIncomePYPct00.04310
IRS990ScheduleA/OtherIncome509Grp/CurrentTaxYearMinus1YearAmt01200
IRS990ScheduleA/OtherIncome509Grp/CurrentTaxYearMinus3YearsAmt02325
IRS990ScheduleA/OtherIncome509Grp/TotalAmt03525
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct00.99870
IRS990ScheduleA/PublicSupportPY509Pct00.95460
IRS990ScheduleA/PublicSupportTotal509Amt05657673
IRS990ScheduleA/SubstAndDsqlfyPrsnsTotGrp/TotalAmt00
IRS990ScheduleA/SubstantialContributorsAmtGrp/TotalAmt00
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt01154745
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt0407480
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt01403812
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt01371975
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt01319661
IRS990ScheduleA/Total509Grp/TotalAmt05657673
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt01154847
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt0408877
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt01404950
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt01375657
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt01320763
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt05665094
IRS990/ScheduleBRequiredInd00
IRS990ScheduleD/DonatedServicesAndUseFcltsAmt07461
IRS990ScheduleD/DonatedServicesUseFcltsAmt07461
IRS990ScheduleD/EquipmentGrp/BookValueAmt06790
IRS990ScheduleD/EquipmentGrp/DepreciationAmt020139
IRS990ScheduleD/EquipmentGrp/OtherCostOrOtherBasisAmt026929
IRS990ScheduleD/ExpensesNotReportedAmt07461
IRS990ScheduleD/ExpensesNotRptFinclStmtAmt00
IRS990ScheduleD/ExpensesSubtotalAmt01269964
IRS990ScheduleD/FootnoteTextInd0X
IRS990ScheduleD/LeaseholdImprovementsGrp/BookValueAmt01573
IRS990ScheduleD/LeaseholdImprovementsGrp/DepreciationAmt0302
IRS990ScheduleD/LeaseholdImprovementsGrp/OtherCostOrOtherBasisAmt01875
IRS990ScheduleD/OtherLandBuildingsGrp/BookValueAmt022756
IRS990ScheduleD/OtherLandBuildingsGrp/DepreciationAmt0492094
IRS990ScheduleD/OtherLandBuildingsGrp/OtherCostOrOtherBasisAmt0514850
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt031232
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt198269
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc0Deferred rent
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc1Clinical trial liabilities
IRS990ScheduleD/RevenueNotReportedAmt07461
IRS990ScheduleD/RevenueNotReportedFinclStmtAmt00
IRS990ScheduleD/RevenueSubtotalAmt01141094
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt0On January 1, 2009, the Foundation adopted the provisions of FASB ASC Topic 740-10 Income Taxes. The implementation of FASB ASC Topic 740-10 had no impact on the Foundation's financial statements and, accordingly, no interest or penalties have been accrued. Management believes it has no material uncertain tax positions or any related penalties and interest to accrue for the year ended March 31, 2022, and accordingly, there is no liability for unrecognized benefits.
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc0Part X, Line 2:
IRS990ScheduleD/TotalBookValueLandBuildingsAmt031119
IRS990ScheduleD/TotalExpensesPerForm990Amt01269964
IRS990ScheduleD/TotalLiabilityAmt0129501
IRS990ScheduleD/TotalRevenuePerForm990Amt01141094
IRS990ScheduleD/TotalRevEtcAuditedFinclStmtAmt01148555
IRS990ScheduleD/TotExpnsEtcAuditedFinclStmtAmt01277425
IRS990ScheduleI/GrantRecordsMaintainedInd01
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/CashGrantAmt012000
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/GrantTypeTxt0Scholarships
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/RecipientCnt05
IRS990/ScheduleJRequiredInd00
IRS990/ScheduleORequiredInd01
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0The Side-Out Foundation was established to educate, empower, and unite the volleyball community through outreach, and drive change in the way that breast cancer is treated by owning and managing its very own game-changing stage IV breast cancer clinical trial, the Side-Out Protocol. Making breast cancer a manageable disease (similar to diabetes) takes an organization with extraordinary vision & cutting-edge tactics. The Side-Out Foundation is a 501(c)(3) non-profit organization, founded in 2004 by Richard and Bryant Dunetz, to empower a new generation of advocates, make significant and identifiable impact on the way breast cancer is treated, and give those living with metastatic breast cancer (MBC) more tomorrows. Since its inception, the foundation has (I) built educational and community-driven programs focused on teaching advocacy to the next generation of changemakers, equipping them with skills and tools to support Side-Out's mission, as well as any cause they wish to connect to in their future; (II) forged groundbreaking collaborations with prestigious research teams, hospitals, and research centers nationwide and; (III) leveraged new technologies to improve, alter cancer trajectories, and constantly challenge the foundation of cancer care so as to significantly extend the lives of those living with MBC. For 10 years the foundation's researchers studied metastatic tumor DNA and the proteins that drive them in a highly targeted research program called The Side-Out Protocol (a direct impact clinical trial managed and operated by Side-Out). This trial was the first and only of its kind to use a multi-omic (genomic, proteomic, and phosphoproteomic analysis) approach along with personalized medicine in the area of MBC research. By using this approach, The Side-Out Protocol provided patients treatment based not on their type of cancer, but on their own cancer cells' molecular architecture. The Side-Out Protocol proved that precision medicine has the ability to significantly extend the lives of those living with the most aggressive stages of breast cancer and that standard level of care as a one-size-fits-all approach is suboptimal and does not benefit every cancer patient. Moving forward, the foundation's goal is to leverage the past 10 years of its precision medicine research to provide patients and their oncologists the information they need to make an informed decision about their cancer journey and to solve some of the most challenging problems in MBC research and care. Side-Out's new metastatic breast cancer research program is available to any and all MBC patients regardless of insurance or previous care at no cost to them. This program gives patients a personalized precision medicine analysis that ranks treatment solutions and clinical trials for which they qualify. For underrepresented racial and ethnic groups, this brings them a level of care previously inaccessible to them. Further, the foundation plans to increase and diversify patient participation through a multi-faceted approach so as to reach patients directly, as well as partner with local and regional cancer centers and oncologists. The result of this will be two-fold: (I) Patients will have the opportunity to take control of their cancer journey and benefit from proven, life-extending science without the financial and emotional burden of traveling to larger cancer centers for care, and (II) These local and regional cancer centers and oncologists can provide their patients access to high-level precision medicine care, services their facilities may not currently be capable of providing due to limited resources. For every patient enrolled in our trials, Side-Out receives biomarker data that can deepen our understanding of MBC and identify evolving trends to improve outcomes. This data set is housed in Side-Out's MBC Bioinformatics Portal where oncologists, biologists, and scientists can access and use the data to further their own research. This revolutionary pro
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1Bryant Dunetz and Rick Dunetz are related.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2The Executive Director and Secretary review the return.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3Written conflict of interest policy is in place and monitored at all levels of the organization.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4The Board reviews and approves compensation for all leadership positions.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt5No other documents are available to the public.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Form 990, Part III, Line 1 - Organization Mission
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1Form 990, Part VI, Section A, line 2
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2Form 990, Part VI, Section B, line 11b
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3Form 990, Part VI, Section B, line 12c
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4Form 990, Part VI, Section B, line 15
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc5Form 990, Part VI, Section C, line 19
IRS990/SchoolOperatingInd00
IRS990/SignificantChangeInd00
IRS990/SignificantNewProgramSrvcInd00
IRS990/StatesWhereCopyOfReturnIsFldCd0AL
IRS990/StatesWhereCopyOfReturnIsFldCd1AR
IRS990/StatesWhereCopyOfReturnIsFldCd2CA
IRS990/StatesWhereCopyOfReturnIsFldCd3FL
IRS990/StatesWhereCopyOfReturnIsFldCd4GA
IRS990/StatesWhereCopyOfReturnIsFldCd5IL
IRS990/StatesWhereCopyOfReturnIsFldCd6KS
IRS990/StatesWhereCopyOfReturnIsFldCd7KY
IRS990/StatesWhereCopyOfReturnIsFldCd8MD
IRS990/StatesWhereCopyOfReturnIsFldCd9MA
IRS990/StatesWhereCopyOfReturnIsFldCd10MI
IRS990/StatesWhereCopyOfReturnIsFldCd11MN
IRS990/StatesWhereCopyOfReturnIsFldCd12MS
IRS990/StatesWhereCopyOfReturnIsFldCd13NH
IRS990/StatesWhereCopyOfReturnIsFldCd14NJ
IRS990/StatesWhereCopyOfReturnIsFldCd15NY
IRS990/StatesWhereCopyOfReturnIsFldCd16NC
IRS990/StatesWhereCopyOfReturnIsFldCd17OH
IRS990/StatesWhereCopyOfReturnIsFldCd18OK
IRS990/StatesWhereCopyOfReturnIsFldCd19PA
IRS990/StatesWhereCopyOfReturnIsFldCd20RI
IRS990/StatesWhereCopyOfReturnIsFldCd21SC
IRS990/StatesWhereCopyOfReturnIsFldCd22UT
IRS990/StatesWhereCopyOfReturnIsFldCd23VA
IRS990/StatesWhereCopyOfReturnIsFldCd24WV
IRS990/StatesWhereCopyOfReturnIsFldCd25WY
IRS990/SubjectToExcsTaxNetInvstIncInd00
IRS990/SubjectToProxyTaxInd00
IRS990/SubjToTaxRmnrtnExPrchtPymtInd00
IRS990/TaxablePartyNotificationInd00
IRS990/TaxExemptBondsInd00
IRS990/TerminateOperationsInd00
IRS990/TotalAssetsBOYAmt02026191
IRS990/TotalAssetsEOYAmt01966126
IRS990/TotalAssetsGrp/BOYAmt02026191
IRS990/TotalAssetsGrp/EOYAmt01966126
IRS990/TotalCompGreaterThan150KInd00
IRS990/TotalContributionsAmt01127967
IRS990/TotalEmployeeCnt08
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt073074
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt0220157

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2022 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$1,966,126
Liabilities
$152,489
Net assets
$1,813,637
Revenue
$1,141,094
Expenses
$1,269,964
Net income
-$128,870
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2025Detailed filing. Detailed filing data is available for this year.$2.11$0.40$1.71$1.48$1.64$0.16
2024XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$2.12$0.25$1.87$1.36$1.19$0.17
2023XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$2.12$0.42$1.70$1.23$1.35$0.12
2022Detailed filing. Detailed filing data is available for this year.$1.97$0.15$1.81$1.14$1.27$0.13
2021Facts available. Structured filing facts are available, but richer extracted sections are limited.$2.03$0.08$1.94$0.40$1.15$0.75
2020Detailed filing. Detailed filing data is available for this year.$2.91$0.22$2.69$1.40$1.51$0.11
2019Detailed filing. Detailed filing data is available for this year.$3.12$0.32$2.80$1.34$1.35$0.00
2018Summary only. Only limited summary data is available for this year.$3.16$0.36$2.81$0.03$0.44$0.41
2017XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$3.56$0.35$3.21$1.32$1.45$0.12
2016Summary only. Only limited summary data is available for this year.$3.37$0.03$3.34$1.53$0.90$0.63
2015Summary only. Only limited summary data is available for this year.$3.18$0.48$2.70$1.40$1.05$0.35
2014Detailed filing. Detailed filing data is available for this year.$2.93$0.57$2.35$1.59$0.81$0.78
2013Detailed filing. Detailed filing data is available for this year.$2.30$0.72$1.57$1.52$2.33$0.81
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$2.39$0.01$2.38$1.16
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$2.53$0.30$2.22$0.75
2010Facts available. Structured filing facts are available, but richer extracted sections are limited.$1.90$0.00$1.90$1.14